Keywords: strong, 3rd, qtr, growth, synaptic, revenues, pharmaceutical
Strong 3rd qtr growth in Synaptic's revenues
Article | 13 November 2000
Synaptic Pharmaceutical Corp has reported third-quarter 2000 revenues of$2.9 million compared with $314,000 in third-quarter 1999. The company says the net loss for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
